The Cooper Companies, Inc. with ticker code (COO) now have 15 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $440.00 and $330.00 and has a mean target at $388.82. Given that the stocks previous close was at $387.50 and the analysts are correct then we can expect a percentage increase in value of .3%. The 50 day moving average now sits at $355.09 and the 200 moving average now moves to $360.72. The company has a market cap of 19.22B. The stock price for the company is currently $388.02 USD
The potential market cap would be $19,282,540,319 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 65.77, revenue per share of $72.59 and a 2.72% return on assets.
The Cooper Companies, Inc. is a global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. CooperVision segment is engaged in developing, manufacturing and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision segment designs its products to solve vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigue, with a broad collection of spherical, toric and multifocal contact lenses. CooperSurgical segment focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women’s health and fertility. CooperSurgical segment supplies the family health care market with a diversified portfolio of products and services. Its office and surgical offerings include products that facilitate surgical and non-surgical procedures that are commonly performed primarily by obstetricians and gynecologists.
